+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Screening - Market Analysis, Trends, and Forecasts

  • ID: 4804177
  • Report
  • October 2019
  • Region: Global
  • 144 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Alere
  • Drägerwerk Ag & Co. Kgaa
  • Lifeloc Technologies
  • Omega Laboratories, Inc.
  • Premier Biotech
  • Quest Diagnostics
  • MORE
The Drug Screening market worldwide is projected to grow by US$5.3 Billion, driven by a compounded growth of 9.8%. Products, one of the segments analyzed and sized in this study, displays the potential to grow at over 9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$7.3 Billion by the year 2025, Products will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$241.6 Million to the region's size and clout in the next 5 to 6 years. Over US$244.6 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Products will reach a market size of US$540.5 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.5% over the next couple of years and add approximately US$905.4 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Alere, Inc.
  • Alfa Scientific Designs, Inc.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Lifeloc Technologies, Inc.
  • Mpd, Inc.
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alere
  • Drägerwerk Ag & Co. Kgaa
  • Lifeloc Technologies
  • Omega Laboratories, Inc.
  • Premier Biotech
  • Quest Diagnostics
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Drug Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Drug Screening Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Drug Screening Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Drug Screening Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Products (Component) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Products (Component) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Products (Component) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Services (Component) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Services (Component) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Services (Component) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Urine (Sample Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Urine (Sample Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Urine (Sample Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Breath (Sample Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Breath (Sample Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Breath (Sample Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Oral Fluid (Sample Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Oral Fluid (Sample Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Oral Fluid (Sample Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Hair (Sample Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Hair (Sample Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Hair (Sample Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Other Sample Types (Sample Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Other Sample Types (Sample Type) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Other Sample Types (Sample Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Drug Screening Market Share (in %) by Company: 2019 & 2025

TABLE 25: United States Drug Screening Market Estimates and Projections in US$ Million by Component: 2018 to 2025

TABLE 26: Drug Screening Market in the United States by Component: A Historic Review in US$ Million for 2009-2017

TABLE 27: United States Drug Screening Market Share Breakdown by Component: 2009 VS 2019 VS 2025

TABLE 28: United States Drug Screening Market Estimates and Projections in US$ Million by Sample Type: 2018 to 2025

TABLE 29: Drug Screening Market in the United States by Sample Type: A Historic Review in US$ Million for 2009-2017

TABLE 30: United States Drug Screening Market Share Breakdown by Sample Type: 2009 VS 2019 VS 2025

CANADA

TABLE 31: Canadian Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2018 to 2025

TABLE 32: Canadian Drug Screening Historic Market Review by Component in US$ Million: 2009-2017

TABLE 33: Drug Screening Market in Canada: Percentage Share Breakdown of Sales by Component for 2009, 2019, and 2025

TABLE 34: Canadian Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2018 to 2025

TABLE 35: Canadian Drug Screening Historic Market Review by Sample Type in US$ Million: 2009-2017

TABLE 36: Drug Screening Market in Canada: Percentage Share Breakdown of Sales by Sample Type for 2009, 2019, and 2025

JAPAN

TABLE 37: Japanese Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2018-2025

TABLE 38: Drug Screening Market in Japan: Historic Sales Analysis in US$ Million by Component for the Period 2009-2017

TABLE 39: Japanese Drug Screening Market Share Analysis by Component: 2009 VS 2019 VS 2025

TABLE 40: Japanese Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Sample Type for the Period 2018-2025

TABLE 41: Drug Screening Market in Japan: Historic Sales Analysis in US$ Million by Sample Type for the Period 2009-2017

TABLE 42: Japanese Drug Screening Market Share Analysis by Sample Type: 2009 VS 2019 VS 2025

CHINA

TABLE 43: Chinese Drug Screening Market Growth Prospects in US$ Million by Component for the Period 2018-2025

TABLE 44: Drug Screening Historic Market Analysis in China in US$ Million by Component: 2009-2017

TABLE 45: Chinese Drug Screening Market by Component: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 46: Chinese Drug Screening Market Growth Prospects in US$ Million by Sample Type for the Period 2018-2025

TABLE 47: Drug Screening Historic Market Analysis in China in US$ Million by Sample Type: 2009-2017

TABLE 48: Chinese Drug Screening Market by Sample Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Drug Screening Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 49: European Drug Screening Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 50: Drug Screening Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 51: European Drug Screening Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 52: European Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2018-2025

TABLE 53: Drug Screening Market in Europe in US$ Million by Component: A Historic Review for the Period 2009-2017

TABLE 54: European Drug Screening Market Share Breakdown by Component: 2009 VS 2019 VS 2025

TABLE 55: European Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2018-2025

TABLE 56: Drug Screening Market in Europe in US$ Million by Sample Type: A Historic Review for the Period 2009-2017

TABLE 57: European Drug Screening Market Share Breakdown by Sample Type: 2009 VS 2019 VS 2025

FRANCE

TABLE 58: Drug Screening Market in France by Component: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 59: French Drug Screening Historic Market Scenario in US$ Million by Component: 2009-2017

TABLE 60: French Drug Screening Market Share Analysis by Component: 2009 VS 2019 VS 2025

TABLE 61: Drug Screening Market in France by Sample Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: French Drug Screening Historic Market Scenario in US$ Million by Sample Type: 2009-2017

TABLE 63: French Drug Screening Market Share Analysis by Sample Type: 2009 VS 2019 VS 2025

GERMANY

TABLE 64: Drug Screening Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Component for the Period 2018-2025

TABLE 65: German Drug Screening Historic Market Analysis in US$ Million by Component: 2009-2017

TABLE 66: German Drug Screening Market Share Breakdown by Component: 2009 VS 2019 VS 2025

TABLE 67: Drug Screening Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Sample Type for the Period 2018-2025

TABLE 68: German Drug Screening Historic Market Analysis in US$ Million by Sample Type: 2009-2017

TABLE 69: German Drug Screening Market Share Breakdown by Sample Type: 2009 VS 2019 VS 2025

ITALY

TABLE 70: Italian Drug Screening Market Growth Prospects in US$ Million by Component for the Period 2018-2025

TABLE 71: Drug Screening Historic Market Analysis in Italy in US$ Million by Component: 2009-2017

TABLE 72: Italian Drug Screening Market by Component: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 73: Italian Drug Screening Market Growth Prospects in US$ Million by Sample Type for the Period 2018-2025

TABLE 74: Drug Screening Historic Market Analysis in Italy in US$ Million by Sample Type: 2009-2017

TABLE 75: Italian Drug Screening Market by Sample Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 76: United Kingdom Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Component for the Period 2018-2025

TABLE 77: Drug Screening Market in the United Kingdom: Historic Sales Analysis in US$ Million by Component for the Period 2009-2017

TABLE 78: United Kingdom Drug Screening Market Share Analysis by Component: 2009 VS 2019 VS 2025

TABLE 79: United Kingdom Market for Drug Screening: Annual Sales Estimates and Projections in US$ Million by Sample Type for the Period 2018-2025

TABLE 80: Drug Screening Market in the United Kingdom: Historic Sales Analysis in US$ Million by Sample Type for the Period 2009-2017

TABLE 81: United Kingdom Drug Screening Market Share Analysis by Sample Type: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 82: Rest of Europe Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2018-2025

TABLE 83: Drug Screening Market in Rest of Europe in US$ Million by Component: A Historic Review for the Period 2009-2017

TABLE 84: Rest of Europe Drug Screening Market Share Breakdown by Component: 2009 VS 2019 VS 2025

TABLE 85: Rest of Europe Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2018-2025

TABLE 86: Drug Screening Market in Rest of Europe in US$ Million by Sample Type: A Historic Review for the Period 2009-2017

TABLE 87: Rest of Europe Drug Screening Market Share Breakdown by Sample Type: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 88: Drug Screening Market in Asia-Pacific by Component: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 89: Asia-Pacific Drug Screening Historic Market Scenario in US$ Million by Component: 2009-2017

TABLE 90: Asia-Pacific Drug Screening Market Share Analysis by Component: 2009 VS 2019 VS 2025

TABLE 91: Drug Screening Market in Asia-Pacific by Sample Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 92: Asia-Pacific Drug Screening Historic Market Scenario in US$ Million by Sample Type: 2009-2017

TABLE 93: Asia-Pacific Drug Screening Market Share Analysis by Sample Type: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 94: Rest of World Drug Screening Market Estimates and Forecasts in US$ Million by Component: 2018 to 2025

TABLE 95: Rest of World Drug Screening Historic Market Review by Component in US$ Million: 2009-2017

TABLE 96: Drug Screening Market in Rest of World: Percentage Share Breakdown of Sales by Component for 2009, 2019, and 2025

TABLE 97: Rest of World Drug Screening Market Estimates and Forecasts in US$ Million by Sample Type: 2018 to 2025

TABLE 98: Rest of World Drug Screening Historic Market Review by Sample Type in US$ Million: 2009-2017

TABLE 99: Drug Screening Market in Rest of World: Percentage Share Breakdown of Sales by Sample Type for 2009, 2019, and 2025

IV. COMPETITION

ALERE

ALFA SCIENTIFIC DESIGNS

DRÄGERWERK AG & CO. KGAA

F. HOFFMANN-LA ROCHE AG

LABORATORY CORPORATION OF AMERICA HOLDINGS

LIFELOC TECHNOLOGIES

MPD

OMEGA LABORATORIES, INC.

ORASURE TECHNOLOGIES

PREMIER BIOTECH

PSYCHEMEDICS CORPORATION

QUEST DIAGNOSTICS

SHIMADZU CORPORATION

SIEMENS HEALTHINEERS

THERMO FISHER SCIENTIFIC

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Alere
  • Alfa Scientific Designs
  • Drägerwerk Ag & Co. Kgaa
  • F. Hoffmann-La Roche Ag
  • Laboratory Corporation of America Holdings
  • Lifeloc Technologies
  • Mpd
  • Omega Laboratories, Inc.
  • Orasure Technologies
  • Premier Biotech
  • Psychemedics Corporation
  • Quest Diagnostics
  • Shimadzu Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll